VKH
HQL

Virtu KCG Holdings’s abrdn Life Sciences Investors HQL Stock Holding History

Virtu KCG Holdings’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-16,782
Closed -$378K – 3674
2015
Q3 		$378K Buy
16,782
+3,222
+24% +$90.2K 0.01% 1823
2015
Q2 		$383K Buy
+13,560
New +$376K 0.01% 1762
2014
Q4 		– Sell
-41,859
Closed -$925K – 3936
2014
Q3 		$925K Buy
41,859
+31,194
+292% +$678K 0.02% 1032
2014
Q2 		$221K Buy
+10,665
New +$224K ﹤0.01% 2944

Other funds holding HQL

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of Nova Scotia
Bank of Nova Scotia Toronto, Ontario, Canada $57.2B AUM 35.3% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Virtu KCG Holdings's HQL Position: Q4 2015 in Review

Virtu KCG Holdings sold out of abrdn Life Sciences Investors (HQL) in Q4 2015, closing a stake of 16,782 shares — an estimated $378K sold.

Virtu KCG Holdings first reported a position in HQL in Q2 2014 and held it in 4 quarters. The position peaked at $925K in Q3 2014. 52 funds tracked by Wall St. Rank hold HQL as of Q4 2015.

  • Virtu KCG Holdings reported no remaining abrdn Life Sciences Investors position as of Q4 2015 after selling out during the quarter.
  • Virtu KCG Holdings sold 16,782 abrdn Life Sciences Investors shares in Q4 2015, an estimated $378K.
  • Virtu KCG Holdings first reported a position in abrdn Life Sciences Investors in Q2 2014 and held it in 4 quarters.
  • Virtu KCG Holdings's abrdn Life Sciences Investors position peaked at $925K in Q3 2014.
  • 52 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q4 2015.

Based on Virtu KCG Holdings's 13F filing for Q4 2015, filed 12 Feb 2016.